University of Ulster joins fight against anthraxOctober 26, 2001The University of Ulster is to become the first university in the world to train nurses to combat bio-terrorism following the spate of anthrax attacks in the US. It has teamed up with the University of Rochester in New York State to develop a joint course that will equip nurses with the skills to treat people exposed to chemical and biological warfare. The course is a development of the University of Ulster's Master of Science degree in disaster relief nursing - the only one of its kind in the world. Students from the University and the University of Rochester will study the joint course simultaneously via the UU's innovative Campus One e-learning initiative. Professor Clive Mulholland, Director of the UU Institute for Lifelong Learning, said: "The University of Rochester is one of our strategic partners in the US and we are looking forward to developing e-learning programmes with them. "They have an excellent school of nursing and there is a natural synergy with our e-learning and nurse training and research expertise, particularly our unique MSc in Disaster Relief nursing. The existing course is being adapted following the terrible terrorist attacks of September 11 and the subsequent anthrax threats". "The anthrax attacks demonstrate the need for proper disaster planning and the need for nurses and other medical experts with the skills to deal with such situations". Currently there are 30 nurses spread over the three years of the disaster relief nursing programme. Seven nurses are already on location at disaster situations in Eastern Europe and Africa. These nurses are involved in research on disaster nursing and will report their findings at a an International Conference to be held at the University of Ulster, Magee campus on 30th August next year. They will also graduate with an MSc in Disaster Relief Nursing and participate in a major disaster simulation exercise that will occur in Northern Ireland in the days following the conference. Pat Deeny, academic co-ordinator for nursing at Magee, said the course prepares nurses for leadership roles while working with multi-national disaster relief teams. "They work in multinational teams that are involved in disasters world-wide. Disasters such as floods, earthquakes, volcanic eruptions or civil wars any event that overwhelms the local healthcare infrastructures. They not only help countries cope with the acute problems of the disaster but also assist with the social reconstruction", he added. Mr Deeny, who is also a member of an international group examining the development of nursing curricula in the USA, said: "The link up with the University of Rochester is an acknowledgement of our expertise in nurse education and research, particularly in the field of disaster relief. We hope that it may prove to be the launch pad for further development of such programmes in the US and world-wide." Professor Hugh McKenna, Head of School stated "This important initiative is one of many collaborations we have made with centres of excellence in the United States and there has been a recent increase in the number of visiting US scholars who wish to come and work with education and research teams in Ulster". Ulster, University of |
|||||||||||||||||||||
| Related Anthrax Current Events and Anthrax News Articles Milestone biodefense publication by Elsevier journal Vaccine Last week during the 'Vaccines for Biothreats and Emerging and Neglected Diseases Symposium' in Galveston TX, USA, the Elsevier journal Vaccine released a supplement dedicated to vaccines for biodefense. Cigarettes Harbor Many Bacteria Harmful to Human Health Cigarettes are "widely contaminated" with bacteria, including some known to cause disease in people, concludes a new international study conducted by a University of Maryland environmental health researcher and microbial ecologists at the Ecole Centrale de Lyon in France. New explanation for nature's hardiest life form Got food poisoning? The cause might be bacterial spores, en extremely hardy survival form of bacteria, a nightmare for health care and the food industry and an enigma for scientists. Better immune defense against anthrax Scientists discover a gene in anthrax-causing bacteria may help defend against this form of bio-warfare. Argonne researchers develop method that aims to stabilize antibodies Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a systematic method to improve the stability of antibodies. Early detection and quick response are key to defense against anthrax attack A large attack on a major metropolitan area with airborne anthrax could affect more than a million people, necessitating their treatment with powerful antibiotics. Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication by the New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug raxibacumab. One secret to how TB sticks with you Mycobacterium tuberculosis is arguably the world's most successful infectious agent because it knows how to avoid elimination by slowing its own growth to a crawl. Unexpected discovery can open a new chapter in the fight against tuberculosis A close relative of the microorganism that causes tuberculosis in humans has been found to form spores. Genetic switch potential key to new class of antibiotics Researchers have determined the structure of a key genetic mechanism at work in bacteria, including some that are deadly to humans, in an important step toward the design of a new class of antibiotics. More Anthrax Current Events and Anthrax News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||